Every day, airlines worldwide face mid-flight medical events: chest pain, fainting, hypoxia, diabetic collapse, stroke symptoms, and severe allergic reactions. Cabin crews are trained in basic first aid — but they are not licensed clinicians.
Without diagnostic data, crew must decide — under extreme pressure — whether to divert the aircraft. That decision costs time, money, and potentially lives.
The crew's tools? A manual first-aid kit, oxygen, and an AED. No ECG. No blood pressure monitor. No glucose sensor. No physician link. No AI guidance. Just a radio.
When a passenger's condition is unclear, decision-making falls on flight crew and airline operations — often under uncertainty, without diagnostic data.
No digital vital-sign monitoring required by regulations. Crew cannot measure ECG, blood pressure, oxygen saturation, glucose, or temperature with any precision.
Ground physicians cannot access real-time patient data. All consultation happens blind — over voice radio — without any clinical readings.
Flight attendants must make quasi-medical decisions with zero AI or clinical support. Misdiagnosis and unnecessary diversions are both common outcomes.
Studies show most diversions could be avoided with better evaluation tools. Each costs $20,000–$250,000 in operational disruption.
AiroAid bridges the gap between what regulations require and what technology can deliver.
See the AiroAid Solution →